Overview


According to FutureWise analysis the market for contrast media or contrast agent in 2023 is US$ 6 billion, and is expected to reach US$ 7.91 billion by 2031 at a CAGR of 3.50%.

Contrast media, or contrast agents, are substances that are used to improve the visibility of internal organs, tissues, and blood vessels during medical imaging procedures such as X-rays, CT scans, and MRI scans. These substances work by absorbing or reflecting the radiation or magnetic fields used in these imaging techniques, resulting in a more detailed and clearer image of the body's internal structures. Contrast media can be administered into the body in various ways, such as through injection, orally, or rectally, depending on the type of imaging procedure being performed. The type of contrast media used also depends on the imaging technique and the specific area of the body being examined.

There are two main types of contrast media: iodinated and gadolinium-based. Iodinated contrast media contain iodine, which absorbs X-rays and is used in X-ray and CT scans. Gadolinium-based contrast media, on the other hand, contain gadolinium, which enhances the visibility of tissues and blood vessels during MRI scans. The use of contrast media is essential in diagnostic imaging procedures as it allows doctors and radiologists to see internal structures more clearly and accurately. Various medical conditions, including cancer, cardiovascular diseases, and neurological disorders, can be detected and diagnosed with the help of this technology.

FutureWise Market Research has published a report that provides an insightful analysis of Contrast Media Or Contrast Agent Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Contrast Media Or Contrast Agent Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • GE Healthcare
  • Bracco Imaging S.P.A
  • Bayer AG
  • Guerbet Group
  • Lantheus Medical Imaging, Inc.
  • Daiichi Sankyo
  • Unijules Life Sciences
  • J.B. Chemicals and Pharmaceuticals Ltd.
  • Sanochemia
  • Magnus Health
  • Taejoon Pharm
  • Jodas Expoim
  • Nano Therapeutics Pvt. Ltd.
  • Kiran X-Ray
  • Interpharma Praha A.S.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Contrast Media Or Contrast Agent Market:

In February 2022, Lopamidal, a generic medicine from Beijing Beilu Pharmaceutical, successfully completed the Consistency Analysis. The analysis helps in comparing the quality and effectiveness of generic medications to those of the brand-name equivalents.

The global contrast media or contrast agent market is expected to experience significant growth, as a result of the increasing incidence of chronic diseases and the rising need for diagnostic imaging procedures, according to expert predictions. The use of contrast media is essential in various medical imaging procedures, such as CT scans, MRI scans, and X-rays, as they enhance the visibility of internal organs, tissues, and blood vessels. The growing prevalence of chronic ilnesses such as cancer, cardiovascular diseases, and neurological disorders has increased the demand for diagnostic imaging procedures, which in turn is driving the growth of the contrast media market. Moreover, advancements in medical imaging technology and the development of new contrast media agents are also contributing to the market's growth. For instance, new contrast agents that provide higher image contrast and fewer adverse effects are being developed and introduced to the market, which is boosting demand. The trend of utilizing interventional radiology is on the rise among healthcare practitioners who prefer less invasive medical procedures and is also driving the growth of the contrast media market. In order to carry out these procedures, it is necessary to use contrast media to guide the insertion of medical devices and the treatment of various diseases.

However, the high cost of contrast media and the chance of encountering unfavorable responses, such as allergies and kidney damage, may hinder the market's growth in some regions. Moreover, the lack of skilled professionals in performing diagnostic imaging procedures may also limit the adoption of contrast media.

By Type

  • Barium-based Contrast Media or Contrast Agents
  • Iodinated Contrast Media or Contrast Agents
  • Gadolinium-based Contrast Media or Contrast Agents
  • Microbubble Contrast Media or Contrast Agents

By Modality

  • X-ray/Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound

By Route of Administration

  • Oral
  • Intravascular
  • Intravenous (IV)
  • Intra-Arterial (IA)
  • Rectal
  • Other Routes

By Indication

  • Cardiovascular Disorders
  • Cancer
  • Gastrointestinal Disorders
  • Musculoskeletal Disorders
  • Neurological Disorders
  • Nephrological Disorders

By Application

  • Radiology
  • Interventional Radiology
  • Interventional Cardiology

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The contrast media or contrast agent market is currently dominated by North America and is projected to maintain this dominance without any significant changes during the forecasted period. In the United States, the first gadolinium-based contrast agent was authorised. Four agents have been authorised in the United States in the last decade, resulting in a strong industry trend to continue to identify more efficient, accurate, and safe agents. Over the next few years, there will be a significant surge in the sales of contrast media in the United States. In particular, the ultrasound industry is set to experience a substantial boost in contrast media sales compared to other imaging modalities. It's worth noting that the United States holds the largest market share for contrast media consumption in North America. The main reason fueling the market's expansion in the US is the rise in chronic illnesses, such as cardiovascular and neurological conditions. Additionally, based on indication; the cardiovascular disorders segment holds the biggest share in the global market in 2022

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Contrast Media or Contrast Agent Market By Type, By Modality, By Route of Administration, By Indication, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction

    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology

    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Contrast Media or Contrast Agent Market Variables, Trends and Scope

    •     1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Contrast Media or Contrast Agent Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Contrast Media or Contrast Agent Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Contrast Media or Contrast Agent Market, By Type Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Barium-based Contrast Media or Contrast Agents
        2. Iodinated Contrast Media or Contrast Agents
        3. Gadolinium-based Contrast Media or Contrast Agents
        4. Microbubble Contrast Media or Contrast Agents

  • 8.   Global Contrast Media or Contrast Agent Market, By Modality Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. X-ray/Computed Tomography (CT)
        2. Magnetic Resonance Imaging (MRI)
        3. Ultrasound

  • 9.   Global Contrast Media or Contrast Agent Market, By Route of Administration Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Oral
        2. Intravascular
         2.1. Intravenous (IV)
         2.2. Intra-Arterial (IA)
        3. Rectal
        4. Other Routes

  • 10.   Global Contrast Media or Contrast Agent Market, By Indication Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Cardiovascular Disorders
        2. Cancer
        3. Gastrointestinal Disorders
        4. Musculoskeletal Disorders
        5. Neurological Disorders
        6. Nephrological Disorders

  • 11.   Global Contrast Media or Contrast Agent Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Radiology
        2. Interventional Radiology
        3. Interventional Cardiology

  • 12.   North America Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 13.   Latin America Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 14.   Europe Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 15.   Asia Pacific Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 16.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)

    •   1. GE Healthcare
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bracco Imaging S.P.A
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bayer AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Guerbet Group
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Lantheus Medical Imaging, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Daiichi Sankyo
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Unijules Life Sciences
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. J.B. Chemicals and Pharmaceuticals Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Sanochemia
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Magnus Health
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Taejoon Pharm
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Jodas Expoim
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Nano Therapeutics Pvt. Ltd.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Kiran X-Ray
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Interpharma Praha A.S.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME key takeaway points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11